- Home
- LGVN vs SBFM Comparison
LGVN vs SBFM Comparison
Compare LGVN & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGVN
- SBFM
- Stock Information
- Founded
- LGVN 2014
- SBFM 2006
- Country
- LGVN United States
- SBFM United States
- Employees
- LGVN N/A
- SBFM N/A
- Industry
- LGVN Medicinal Chemicals and Botanical Products
- SBFM Biotechnology: Pharmaceutical Preparations
- Sector
- LGVN Health Care
- SBFM Health Care
- Exchange
- LGVN Nasdaq
- SBFM Nasdaq
- Market Cap
- LGVN 30.0M
- SBFM 3.7M
- IPO Year
- LGVN 2021
- SBFM N/A
- Fundamental
- Price
- LGVN $2.05
- SBFM $3.14
- Analyst Decision
- LGVN Strong Buy
- SBFM
- Analyst Count
- LGVN 2
- SBFM 0
- Target Price
- LGVN $8.00
- SBFM N/A
- AVG Volume (30 Days)
- LGVN 393.9K
- SBFM 90.8K
- Earning Date
- LGVN 11-08-2024
- SBFM 11-11-2024
- Dividend Yield
- LGVN N/A
- SBFM N/A
- EPS Growth
- LGVN N/A
- SBFM N/A
- EPS
- LGVN N/A
- SBFM N/A
- Revenue
- LGVN $1,229,000.00
- SBFM $30,481,982.00
- Revenue This Year
- LGVN $161.78
- SBFM $86.70
- Revenue Next Year
- LGVN $8.62
- SBFM $126.76
- P/E Ratio
- LGVN N/A
- SBFM N/A
- Revenue Growth
- LGVN 39.34
- SBFM 109.82
- 52 Week Low
- LGVN $0.77
- SBFM $2.42
- 52 Week High
- LGVN $23.90
- SBFM $660.00
- Technical
- Relative Strength Index (RSI)
- LGVN 52.20
- SBFM 52.62
- Support Level
- LGVN $1.76
- SBFM $2.85
- Resistance Level
- LGVN $2.26
- SBFM $3.05
- Average True Range (ATR)
- LGVN 0.12
- SBFM 0.14
- MACD
- LGVN 0.05
- SBFM 0.03
- Stochastic Oscillator
- LGVN 58.00
- SBFM 85.29
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. The company is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA targeted for liver cancer, (ii) SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections, and (iii) Adva-27a for pancreatic cancer. The company has two reportable segments: Prescription Generic Pharmaceuticals ("Generic Pharmaceuticals") and Nonprescription Over-The-Counter Products ("OTC Products"). The company generates the majority of its revenue from the Generic Pharmaceuticals segment.